6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: June 25, 2018
Period of Report: June 25, 2018
Accession Number: 0001157523-18-001334

View Document ↗ View on SEC.gov ↗